Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-11 @ 3:23 PM
Study NCT ID:
NCT01665768
Status:
COMPLETED
Last Update Posted:
2021-10-26
First Post:
2012-07-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Conditions & Keywords Data
Conditions:
Keywords: